THE HSE has issued a drug warning ahead of the St Patrick’s Day weekend amid concerns over “highly potent” powders, crystals and pills. Health experts are warning that the Irish drug ...

MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

The Food and Drug Administration (FDA) declined on Friday to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD). The agency has asked Lykos Therapeutics, ...

When making regulatory decisions about a drug, the U.S. Food and Drug Administration (FDA) often relies on advisory committees to provide independent advice. (U.S. Food & Drug Admin., Learn About FDA ...

There are no 'safe use guarantees', but it's possible to reduce harm.

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.

The Food and Drug Administration on Friday rejected a California drug company's request to market the psychedelic drug MDMA combined with talk therapy as a treatment for post-traumatic stress disorder ...

Researchers found that psilocybin and MDMA may alleviate PTSD symptoms by promoting myelin remodeling in the brain. In rat ...

A San Francisco-based biotech company, backed by OpenAI’s Sam Altman, has won government approval to begin clinical trials of a new “safer MDMA”. The company, Arcadia Medicine, which is developing ...

Under the agreement, PharmAla will provide its LaNeo™ MDMA at no charge to Spaulding Rehabilitation for use in a study entitled “Hyperscan Neuroimaging to Reveal the Brain Mechanisms Supporting ...

A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.